Sign in / Sign up
← Back to investors

NVentures

投资主体(类型未细分)

Website ↗
Verified investment lower bound—
Investment cases15
Manager operating history4 years

Representative investments

#CompanyMarket cap / valuationUSDTotal fundingUSDLast financing / listingKey investors
20Skild AI美国>$14BPrivate valuation
Sources · 1
≥$1.4BVerified lower bound$1.4BSeries C
Sources · 1
21Lovable瑞典$13.3BPrivate valuation
Sources · 1
≥$730MVerified lower bound$400MSeries C
Sources · 1
42Ricursive Intelligence美国$4BPrivate valuation
Sources · 1
≥$300MVerified lower bound$300MSeries A
Sources · 1
43Synthesia英国$4BPrivate valuation
Sources · 1
≥$380MVerified lower bound$200MSeries E
Sources · 1
45Decart美国$3.96BPrivate valuation
Sources · 1
≥$300MVerified lower bound$300MSeries B
Sources · 1
98XBOW美国>$1BPrivate valuation
Sources · 1
≥$155MVerified lower bound整轮含此前120及追加35$155MSeries C扩募后整轮总额
Sources · 1
—DYNA Robotics美国—Private valuation
Sources · 1
≥$120MVerified lower bound$120MSeries A
Sources · 1
—EvolutionaryScale美国—Private valuation
Sources · 1
≥$142MVerified lower bound$142MSeed
Sources · 1
—Inceptive美国—Private valuation
Sources · 1
≥$120MVerified lower bound$100MSeries A
Sources · 1
—Bedrock Robotics美国—Private valuation
Sources · 1
≥$350MVerified lower bound$270MSeries B
Sources · 1
—n8n德国—Private valuation
Sources · 1
≥$240MVerified lower bound—战略投资
Sources · 1
—Abridge美国—Private valuation
Sources · 1
≥$250MVerified lower bound—战略投资
Sources · 1
—Genesis Molecular AI(原Genesis Therapeutics)美国—Private valuation
Sources · 1
≥$280MVerified lower bound$200MSeries B
Sources · 1
—Lila Sciences美国—Private valuation
Sources · 1
≥$550MVerified lower bound$350MSeries A
Sources · 1
—PolyAI英国/美国—Private valuation
Sources · 1
≥$200MVerified lower bound$86MSeries D
Sources · 1
Reviewed through 2026-10-24 · Snapshot 2026-10-24-b30adb247c2f